-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on HNI, Lowers Price Target to $65

Benzinga·05/07/2026 14:33:08
Listen to the news
Benchmark analyst Reuben Garner maintains HNI (NYSE:HNI) with a Buy and lowers the price target from $75 to $65.